Eric Coldwell
Stock Analyst at Baird
(5.00)
# 8
Out of 4,853 analysts
192
Total ratings
56.48%
Success rate
124.07%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Neutral | $19 → $22 | $23.12 | -4.84% | 8 | May 15, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $118 → $140 | $145.13 | -3.53% | 14 | May 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $195 → $161 | $151.71 | +6.12% | 17 | May 7, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Neutral | $192 → $160 | $138.51 | +15.52% | 20 | May 2, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $156 → $170 | $154.07 | +10.34% | 12 | May 2, 2025 | |
| LH Labcorp Holdings | Maintains: Outperform | $253 → $267 | $252.08 | +5.92% | 13 | Apr 30, 2025 | |
| MEDP Medpace Holdings | Maintains: Neutral | $340 → $313 | $299.94 | +4.35% | 18 | Apr 23, 2025 | |
| DGX Quest Diagnostics | Maintains: Outperform | $191 → $194 | $174.63 | +11.09% | 10 | Apr 23, 2025 | |
| OMI Owens & Minor | Maintains: Neutral | $10 → $11 | $7.83 | +40.49% | 17 | Mar 3, 2025 | |
| AHCO AdaptHealth | Maintains: Outperform | $14 → $16 | $9.05 | +76.80% | 10 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $25 | $5.14 | +386.38% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $531 → $688 | $707.52 | -2.76% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $51 | $11.26 | +353.13% | 16 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $45 | $56.52 | -20.38% | 2 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $66 | $63.39 | +4.12% | 7 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $46 | $1.51 | +2,946.36% | 4 | Nov 10, 2017 |
Premier
May 15, 2025
Maintains: Neutral
Price Target: $19 → $22
Current: $23.12
Upside: -4.84%
Charles River Laboratories International
May 8, 2025
Maintains: Neutral
Price Target: $118 → $140
Current: $145.13
Upside: -3.53%
IQVIA Holdings
May 7, 2025
Maintains: Neutral
Price Target: $195 → $161
Current: $151.71
Upside: +6.12%
ICON Public Limited Company
May 2, 2025
Maintains: Neutral
Price Target: $192 → $160
Current: $138.51
Upside: +15.52%
Cardinal Health
May 2, 2025
Maintains: Outperform
Price Target: $156 → $170
Current: $154.07
Upside: +10.34%
Labcorp Holdings
Apr 30, 2025
Maintains: Outperform
Price Target: $253 → $267
Current: $252.08
Upside: +5.92%
Medpace Holdings
Apr 23, 2025
Maintains: Neutral
Price Target: $340 → $313
Current: $299.94
Upside: +4.35%
Quest Diagnostics
Apr 23, 2025
Maintains: Outperform
Price Target: $191 → $194
Current: $174.63
Upside: +11.09%
Owens & Minor
Mar 3, 2025
Maintains: Neutral
Price Target: $10 → $11
Current: $7.83
Upside: +40.49%
AdaptHealth
Feb 27, 2025
Maintains: Outperform
Price Target: $14 → $16
Current: $9.05
Upside: +76.80%
Dec 6, 2024
Downgrades: Neutral
Price Target: $28 → $25
Current: $5.14
Upside: +386.38%
Nov 7, 2024
Upgrades: Outperform
Price Target: $531 → $688
Current: $707.52
Upside: -2.76%
Apr 1, 2022
Downgrades: Neutral
Price Target: $51
Current: $11.26
Upside: +353.13%
Jun 26, 2020
Maintains: Neutral
Price Target: $35 → $45
Current: $56.52
Upside: -20.38%
May 7, 2020
Maintains: Neutral
Price Target: $62 → $66
Current: $63.39
Upside: +4.12%
Nov 10, 2017
Maintains: Outperform
Price Target: $67 → $46
Current: $1.51
Upside: +2,946.36%